Navigation Links
Broncus Technologies' Exhale Stent and Other New Devices to Prompt Robust Growth In Emphysema Treatment Market, According to Millennium Research Group
Date:6/16/2009

WALTHAM, Mass., June 16 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the rise in the US prevalence of emphysema is prompting device firms to develop endoscopic devices used to diagnose or treat the condition. Currently, only two surgical treatment options for emphysema are available: lung volume reduction or lung transplant, both of which involve substantial risks for the patient. MRG's US Markets for ENT and Bronchoscopy Devices 2009 finds that the minimally invasive devices in development, anticipated to launch in the US market over the next five years, will offer more options for these patients.

Devices such as Spiration's IBV Valve System, Broncus Technologies' Exhale stent, Aeris Therapeutics' Polymeric Lung Volume Reduction System, and PneumRX's steerable biopsy needles have undergone at least phase I clinical testing in the US. Some of these technologies are expected to receive FDA approval before 2013, bringing minimally invasive technology to the emphysema patient population.

"The release of these minimally invasive devices will create new market opportunities and will positively affect the existing market for flexible bronchoscopes, which will act as conduits for many of the new devices used," says Tiffanie Demone, Senior Analyst at MRG. "By 2013, the white light video flexible bronchoscope market will experience growth of more than 13%."

MRG's US Markets for ENT and Bronchoscopy Devices 2009 report provides an affordable, off-the-shelf solution to tracking important ENT and bronchoscopy market segments and competitor dynamics. This report allows clients to assess the effect of the economic downturn, plan for the future, tap into deep segmentation, and leverage downturn-adjusted 5-year forecasts, up-to-date market shares, and in-depth qualitative insights.

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack(TM) projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the health care industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Amy Krohn
    Millennium Research Group
    416-364-7776 x101
    akrohn@mrg.net

    Elizabeth Marshall
    Decision Resources Inc.
    781-296-2563
    emarshall@dresources.com


'/>"/>
SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
2. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
3. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
4. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
5. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
6. Advanced technologies aim to transform the coaching of top athletes
7. Global Med Technologies(R) Extends Its Worldwide Outreach
8. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
9. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
10. Neurobiological Technologies Reports Going Concern Qualification
11. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... Clinical Conductor CTMS, which provides a modern CTMS workflow designed to seamlessly integrate ... information has been condensed to a single page, maximizing usability and improving efficiency ...
(Date:1/19/2017)... ... January 19, 2017 , ... Workrite ... system. , The Tranquility privacy panel system was designed to deliver the ... panels help reduce noise and provide the visual privacy required to maintain concentration ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... and financial planning services to communities throughout eastern Georgia, is embarking on a ... disease. , Heart disease kills more Americans every year than anything else, yet ...
(Date:1/19/2017)... ... January 19, 2017 , ... Attorney Robert “RC” Pate ... year donated money to the Triumph Over Kid Cancer foundation. Each year, 175,000 children ... those children. James saw firsthand the effect of the critical funding gap for research ...
(Date:1/19/2017)... ... January 19, 2017 , ... Bill Howe Plumbing, Heating & Air in ... Association; “Howe” Healthy is Your Heart Drawing Contest The drawing contest asks ... Bill Howe Plumbing, Heating & Air receives over 600 entries. The culmination of the ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Conference Call and Webcast to Follow Vanda ... will release results for the fourth quarter of 2016 on Wednesday, ... ... at 4:30 PM ET on Wednesday, February 15, 2017, during which ... results and other corporate activities. To participate in the conference call, ...
(Date:1/19/2017)... Jan. 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ... mitochondrial dysfunction, today announced new additions to its senior ... Chief Medical Officer, and Daniel Geffken as ... Jim Carr , Pharm.D. has been promoted to ... pleased to welcome Doug and Daniel to our management ...
(Date:1/19/2017)... 2017  Abaxis, Inc. (NasdaqGS: ABAX ), ... and consumables for the medical and veterinary markets worldwide, ... results for the third quarter fiscal year 2017, ended ... p.m. ET on Thursday, January 26, 2017.  The Company ... year 2017 after the market closes on Thursday, January ...
Breaking Medicine Technology: